Rapid risk assessment: Public health risks related to communicable diseases during the 2018 Hajj, Saudi Arabia, 19–24 August 2018
The aim of this document is to assess the potential health risks related to communicable diseases and other health threats for EU/EEA citizens during their stay in Saudi Arabia for the Hajj pilgrimage between 19 and 24 August 2018.
Due to the vaccination requirements for travelling to Mecca, Saudi Arabia, and the preparedness plans put in place by the host country addressing the management of health hazards during and after the Hajj, the overall risk for EU/EEA citizens of becoming infected with a contagious disease during the 2018 Hajj in Saudi Arabia is considered to be low. The risk of communicable disease outbreaks is highest for food- and waterborne diseases and respiratory illnesses, but the risk is not considered higher than can generally be expected for international mass gatherings of this size. MERS-CoV activity continues to be reported in the Arabian Peninsula, specifically from Saudi Arabia, and therefore imported cases may be detected in Europe following the Hajj. The risk of transmission of other vaccine-preventable and vector-borne diseases is considered to be low. The national health authorities in countries from where Muslims embark on the Hajj pilgrimage to Mecca should apply appropriate strategies for the prevention and control of communicable diseases before, during and after the completion of the Hajj.
Latest risk assessments
Rapid risk assessment - Sexual transmission of dengue in Spain
18 Nov 2019 - Spanish authorities have reported the likely sexual transmission of dengue between two men. One of the men travelled to Cuba and the Dominican Republic (both countries where dengue is endemic) and returned to Spain on 4 September 2019.
Outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae ST307, north-east Germany, 2019
28 Oct 2019 - Germany has reported an outbreak of carbapenemase-producing (NDM-1 and OXA-48) and colistin-resistant Klebsiella pneumoniae sequence type (ST) 307. As of 21 October 2019, 17 patients in three hospitals and one rehabilitation clinic in Mecklenburg-West Pomerania in north-east Germany have been affected. Six of the 17 cases presented with clinical symptoms of infection, while 11 were identified as be carriers.
Rapid risk assessment: Zika virus disease in Var department, France
16 Oct 2019 - On 1 October 2019, a case of locally acquired Zika virus (ZIKV) disease in France (Hyères city, Var department) was laboratory confirmed. To date, and based on ECDC’s epidemiological assessment, the probability of ongoing vector-borne local transmission in Hyères (and surrounding areas) is considered very low because current evidence does not indicate the existence of a more extensive cluster of ZIKV cases.